Farid Badria1, Eman Mazyed2. 1. Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. 2. Department of Pharmaceutical Technology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
Abstract
PURPOSE: The current study aimed to discuss the potential of nanospanlastics as a surfactant-based vesicular system for improving the topical delivery of 3-acetyl-11-keto-β-boswellic acid (AKBA). AKBA is a potent anti-inflammatory drug, but it has poor oral bioavailability due to its poor aqueous solubility. Moreover, the topical delivery of AKBA is difficult due to its high lipophilicity. To overcome these drawbacks, AKBA was formulated as deformable elastic nanovesicles and nanospanlastics, for improving its topical delivery. MATERIALS AND METHODS: AKBA-loaded spanlastic nanovesicles (SNVs) were formulated by ethanol injection technique according to 23 factorial design using Span 60 as a non-ionic surfactant and Tween 80 as edge activator (EA) to investigate the effect of different independent variables on entrapment efficiency (EE%), % drug released after 8 hr (Q8h) and particle size (PS) using Design-Expert software. In vitro characterization, stability test and ex vivo permeation study of the optimized formula were performed. RESULTS: The choice of the optimized formula was based on the desirability criteria. F7 was selected as the optimized formula because it has the highest desirability value of 0.648. F7 exhibited EE% of 90.04±0.58%, Q8h of 96.87±2.67%, PS of 255.8±2.67 nm, and zeta potential of -49.56 mV. F7 appeared as spherical well-defined vesicles in both scanning electron microscope (SEM) and transmission electron microscope (TEM). The Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) studies investigated the absence of interaction between AKBA and different excipients and good encapsulation of AKBA within SNVs. F7 retained both physical and chemical stability after storage for 3 months at 4-8 °C. Ex vivo permeation test exhibited significant enhancement of permeability of F7 across rat skin than the free drug. CONCLUSION: Nanospanlastics could be a promising approach for improving the permeability and topical delivery of AKBA.
PURPOSE: The current study aimed to discuss the potential of nanospanlastics as a surfactant-based vesicular system for improving the topical delivery of 3-acetyl-11-keto-β-boswellic acid (AKBA). AKBA is a potent anti-inflammatory drug, but it has poor oral bioavailability due to its poor aqueous solubility. Moreover, the topical delivery of AKBA is difficult due to its high lipophilicity. To overcome these drawbacks, AKBA was formulated as deformable elastic nanovesicles and nanospanlastics, for improving its topical delivery. MATERIALS AND METHODS: AKBA-loaded spanlastic nanovesicles (SNVs) were formulated by ethanol injection technique according to 23 factorial design using Span 60 as a non-ionic surfactant and Tween 80 as edge activator (EA) to investigate the effect of different independent variables on entrapment efficiency (EE%), % drug released after 8 hr (Q8h) and particle size (PS) using Design-Expert software. In vitro characterization, stability test and ex vivo permeation study of the optimized formula were performed. RESULTS: The choice of the optimized formula was based on the desirability criteria. F7 was selected as the optimized formula because it has the highest desirability value of 0.648. F7 exhibited EE% of 90.04±0.58%, Q8h of 96.87±2.67%, PS of 255.8±2.67 nm, and zeta potential of -49.56 mV. F7 appeared as spherical well-defined vesicles in both scanning electron microscope (SEM) and transmission electron microscope (TEM). The Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) studies investigated the absence of interaction between AKBA and different excipients and good encapsulation of AKBA within SNVs. F7 retained both physical and chemical stability after storage for 3 months at 4-8 °C. Ex vivo permeation test exhibited significant enhancement of permeability of F7 across rat skin than the free drug. CONCLUSION: Nanospanlastics could be a promising approach for improving the permeability and topical delivery of AKBA.
Authors: Dina Mahmoud Mostafa; Nagwa Mohammed Ammar; Mona Basha; Rehab Ali Hussein; Sally El Awdan; Gamal Awad Journal: Drug Deliv Date: 2014-04-14 Impact factor: 6.419
Authors: Aml I Mekkawy; Nermin E Eleraky; Ghareb M Soliman; Mohamed G Elnaggar; Marwa G Elnaggar Journal: Pharmaceutics Date: 2022-08-18 Impact factor: 6.525
Authors: Nabil A Alhakamy; Mohammed W Al-Rabia; Shadab Md; Alaa Sirwi; Selwan Saud Khayat; Sahar Saad AlOtaibi; Raghad Abkar Hakami; Hadeel Al Sadoun; Basmah Medhat Eldakhakhny; Wesam H Abdulaal; Hibah M Aldawsari; Shaimaa M Badr-Eldin; Mahmoud A Elfaky Journal: Pharmaceutics Date: 2021-06-28 Impact factor: 6.321
Authors: Randa Mohammed Zaki; Munerah M Alfadhel; Saad M Alshahrani; Ahmed Alsaqr; Layla A Al-Kharashi; Md Khalid Anwer Journal: Pharmaceuticals (Basel) Date: 2022-03-13